Iwamoto, Takayuki http://orcid.org/0000-0001-5835-5160
Niikura, Naoki
Watanabe, Kenichi
Takeshita, Takashi
Kikawa, Yuichiro
Kobayashi, Kokoro
Iwakuma, Nobutaka
Okamura, Takuho
Tada, Hiroshi
Ozaki, Shinji
Okuno, Toshitaka
Toh, Uhi
Yamamoto, Yutaka
Tsuneizumi, Michiko
Ishiguro, Hiroshi
Masuda, Norikazu
Saji, Shigehira
Funding for this research was provided by:
AstraZeneca K.K.
Article History
Received: 15 May 2023
Accepted: 25 September 2023
First Online: 25 October 2023
Declarations
:
: T Iwamoto: research grant from Pfizer; N Niikura: research grant from Chugai, Pfizer, Eisai, Mochida, Daiichi Sankyo and Novartis and honoraria for lectures from Chugai, Eli Lilly, MSD, Daiichi-Sankyo, AstraZeneca and Pfizer; K Watanabe: honoraria for lectures from Chugai, Eli Lilly, Nippon-Kayaku, Kyowa-Kirin, Novartis, Taiho, Eisai, Pfizer, Shionogi, Daiichi-Sankyo and AstraZeneca; Y Kikawa: honoraria for lectures from Eisai, Novartis, Astra Zeneca, Taiho, Pfizer, Daiichi Sankyo, Lilly and Chugai; K Kobayashi: honoraria for lectures from Pfizer, Taiho, Chugai, Astrazeneca, Eli Lilly, Eisai and Novartis; H Tada: research grant from Daiichi Sankyo, Eli Lilly, Kirin, Chugai, Novartis, Taiho; U Toh: research grant from Chugai, Eisai, Taiho, Nippon Kayaku and honoraria for lectures from Pfizer, Kyowa-Kirin, Eli Lilly and Daiichi Sankyo; Y Yamamoto: research grant from Chugai, Kyowa-Kirin, Eisai, Daiichi-Sankyo, Nippon-Kayaku, Taiho, Takeda, Lilly, Pfizer and Novartis, honoraria for lectures from AstraZeneca, Chugai, Kyowa-Kirin, Novartis, Lilly, Pfizer, Daiichi-Sankyo, Nippon-Kayaku, Taiho, Eisai, Takeda, MSD, Sysmex and Exact Science, Advisory Board: AstraZeneca, Chugai, Novartis, MSD, Lilly, Pfizer and Daiichi-Sankyo and Member of the Board of Directors at Japanese Breast Cancer Society and Japan Breast Cancer Research Group; H Ishiguro: research grant from Eisai, Daiichi sankyo, Takeda and Chugai and honoraria for lectures from Eisai, Pfizer, Daiichi sankyo, Chugai and Kyowa Kirin; N Masuda: research grant from Chugai, Eli Lilly, Astra Zeneca, Pfizer, Daiichi-Sankyo, MSD, Eisai, Novartis, Sanofi, Kyowa-Kirin, Nippon-Kayaku and Ono-Pharma, honoraria for lectures from Chugai, Pfizer, Astra Zeneca, Eli Lilly, Daiichi Sankyo and Eisai and Board of Directors at Japanese Breast Cancer Society; S Saji: research grant from Taiho, Eisai, Chugai, Takeda, MSD, Astra Zeneca and Daiichi Sankyo, honoraria for lectures from Chugai, Kyowa Kirin, MSD, Novartis, Eisai, Takeda, Daiichi Sankyo, Eli Lilly, Astra Zeneca, Pfizer, Taiho, Ono and Nipponkayaku, Participation on a Data Safety Monitoring Board or Advisory Board at Chugai/Roche, Astra Zeneca, Eli Lilly, Pfizer, Kyowa Kirin, Daiichi Sankyo and MSD and Executive board member at JBCRG, JBCS, JSMO and BIG. The others have no competing interests.
: This study received an approval from the Ethics Committee of Fukushima Medical University School of Medicine and the respective institution.
: Informed consent was obtained from all individual participants included in the study.
: All study participant consent for publication of this study.